Print ISSN:-

Online ISSN:-2583-4614

Article History

Received : 27-10-2024

Accepted : 28-11-2024



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 105

PDF Downloaded: 43


Epstein-Barr virus-associated lymphoproliferative disorder mimicking Hodgkin’s lymphoma in immunocompetent patients: A case report and literature review


Full Text PDF


Case Report

Author Details : Sumaira Kanwal Rafiqui*, Mamunul Islam

Volume : 3, Issue : 3, Year : 2024

Article Page : 247-251

https://doi.org/10.18231/j.yjom.2024.027



Suggest article by email

Abstract

Epstein-Barr virus (EBV) is the most common infectious agent associated with hemophagocytic lymphohistiocytosis (HLH). This case report discusses a 24-year-old immunocompetent African male presenting with a five-month history of persistent high-grade fever, pancytopenia, and splenomegaly. Initial diagnostic evaluations, including bone marrow biopsy, suggested Hodgkin lymphoma; however, further lymph node biopsy, repeated bone marrow biopsy and comprehensive clinical assessment confirmed EBV-associated lymphoproliferative disorder with HLH. This case underscores the importance of thorough diagnostic approaches, incorporating multiple biopsy sites and advanced imaging, to differentiate between EBV-associated HLH and hematological malignancies such as lymphomas. Enhanced clinical awareness and understanding of HLH's diverse presentations are essential for timely diagnosis and effective management.


Keywords: Hemophagocytic lymphohistiocytosis (HLH), Epstein­Bar Virus (EBV), lymphoproliferative disorders



How to cite : Rafiqui S K, Islam M, Epstein-Barr virus-associated lymphoproliferative disorder mimicking Hodgkin’s lymphoma in immunocompetent patients: A case report and literature review. Yemen J Med 2024;3(3):247-251


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International, which allows others to remix, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.